Jennifer E Hibma

Affiliations
  • Pfizer Global Product Development, La Jolla, California, USA.

Publications (5)

Pharmacokinetic/Pharmacodynamic Modeling to Support the Re-approval of Gemtuzumab Ozogamicin.

Clinical pharmacology and therapeutics
Avec: Luke K Fostvedt , Jennifer E Hibma , Joanna C Masters , Erik Vandendries , Ana Ruiz-Garcia

Clinical Pharmacology Worldwide: A Global Health Perspective.

Clinical pharmacology and therapeutics
Avec: Larissa Wenning , Goonaseelan Colin Pillai , Todd C Knepper , Katarina Ilic , Ali Mohamed Ali , Jennifer E Hibma

Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants.

Cancer chemotherapy and pharmacology
Avec: Jennifer E Hibma , Melissa O'Gorman , Sunil Nepal , Sylvester Pawlak , Katherine Ginman , Yazdi K Pithavala

Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modelling.

British journal of clinical pharmacology
Avec: Jennifer E Hibma , Hagop M Kantarjian , Daniel J DeAngelo , Joseph P Boni

Disease progression modeling of the North Star Ambulatory Assessment for Duchenne Muscular Dystrophy.

CPT: pharmacometrics & systems pharmacology
Avec: Jennifer E Hibma , Priya Jayachandran , Srividya Neelakantan , Lutz O Harnisch

Réseau de co-auteurs

Luke K Fostvedt 1 collaboration
Joanna C Masters 1 collaboration
Erik Vandendries 1 collaboration
Ana Ruiz-Garcia 1 collaboration
Larissa Wenning 1 collaboration
Goonaseelan Colin Pillai 1 collaboration
Todd C Knepper 1 collaboration
Katarina Ilic 1 collaboration
Ali Mohamed Ali 1 collaboration
Melissa O'Gorman 1 collaboration
Sunil Nepal 1 collaboration
Sylvester Pawlak 1 collaboration
Katherine Ginman 1 collaboration
Yazdi K Pithavala 1 collaboration
Hagop M Kantarjian 1 collaboration
Daniel J DeAngelo 1 collaboration
Joseph P Boni 1 collaboration
Priya Jayachandran 1 collaboration
Srividya Neelakantan 1 collaboration
Lutz O Harnisch 1 collaboration